Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Amortization of Deferred Charges: 2023-2025

Historic Amortization of Deferred Charges for Lifecore Biomedical (LFCR) over the last 1 years, with May 2025 value amounting to $6.8 million.

  • Lifecore Biomedical's Amortization of Deferred Charges rose 12.68% to $6.8 million in Q2 2025 from the same period last year, while for May 2025 it was $20.2 million, marking a year-over-year increase of 31.12%. This contributed to the annual value of $20.2 million for FY2025, which is 31.12% up from last year.
  • Per Lifecore Biomedical's latest filing, its Amortization of Deferred Charges stood at $6.8 million for Q2 2025, which was up 46.78% from $4.6 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Amortization of Deferred Charges registered a high of $6.8 million during Q2 2025, and its lowest value of $3.0 million during Q3 2023.
  • Over the past 3 years, Lifecore Biomedical's median Amortization of Deferred Charges value was $4.4 million (recorded in 2024), while the average stood at $4.5 million.
  • Data for Lifecore Biomedical's Amortization of Deferred Charges shows a peak YoY soared of 56.00% (in 2024) over the last 5 years.
  • Over the past 3 years, Lifecore Biomedical's Amortization of Deferred Charges (Quarterly) stood at $3.1 million in 2023, then soared by 31.02% to $4.1 million in 2024, then climbed by 12.68% to $6.8 million in 2025.
  • Its Amortization of Deferred Charges stands at $6.8 million for Q2 2025, versus $4.6 million for Q1 2025 and $4.1 million for Q4 2024.